Identification of multiple potential triggers in sarcoidosis patients

Completed

• Conditions: M. Besnier-Boeck-Schaumann; Sarcoidosis; 10006436; 10003816

• Registration Number: NL-OMON44530
• Lead Sponsor: Sint Antonius Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1114

Inclusion Criteria

Biopsy proven diagnosis of Sarcoidosis

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To determine the prevalence of sensitization against mycobacteria,<br /><br>propionibacteria and metals including beryllium, aluminium and zirconium in<br /><br>sarcoidosis patients</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Compare the classical lymphocyte proliferation test with the interferon gamma<br /><br>release assay</p><br>